Navigation Links
Common Drug Eases Leg Pain From Walking
Date:5/14/2008

More than half taking naftidrofuryl, a blood vessel medication, improved distances 50%

WEDNESDAY, May 14 (HealthDay News) -- The prescription drug naftidrofuryl eases leg cramps caused by narrowing blood vessels and enables patients to walk farther, according to Belgian researchers.

They reviewed seven studies of 1,266 people with the painful condition called intermittent claudication. Patients who took the typical 200-milligram dose of naftidrofuryl (which relaxes blood vessels) three times a day for six months could walk about 40 percent farther without pain than those who took a placebo. More than half the patients who took the drug improved their walking distance by more than 50 percent, compared to just over one-third of patients who took a placebo. On average, patients who took the drug walked about 93 more yards.

The findings were published in the current issue of the Cochrane Library journal.

"Being able to walk that extra distance and have less pain makes an important, meaningful difference for these patients," study author Dr. Tine De Backer, a cardiologist at the Heart Center and at the Heymans Institute of Pharmacology at Ghent University, said in a prepared statement.

Naftidrofuryl only treats the type of leg cramping that's a symptom of intermittent claudication, but not the cause of the condition, which is peripheral artery disease (PAD), De Backer noted.

PAD is hardening and narrowing of the blood vessels typically associated with diabetes, smoking, high blood pressure, a sedentary lifestyle, elevated blood lipids and aging. PAD affects one in 20 Americans over age 50, according to the U.S. National Heart, Lung, and Blood Institute. People with type 2 diabetes have an especially high risk of PAD and intermittent claudication.

While naftidrofuryl can help patients with intermittent claudication, the review authors emphasized that quitting smoking, getting more exercise and eating a healthy diet are the first line of defense against PAD and resulting intermittent claudication.

However, doctors should prescribe naftidrofuryl for intermittent claudication, "if patients cannot control their symptoms with the drug treatments they are already on, and if they are still in pain after making lifestyle modifications," De Backer said.

More information

The American Academy of Family Physicians has more about PAD and claudication.



-- Robert Preidt



SOURCE: Center for the Advancement of Health, news release, May 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. NightHawk Radiology Holdings, Inc. Announces Dutch Tender Offer for Its Common Stock
2. Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety
3. Problem Gambling Common Among Young Adults
4. Data Show Common Allergy Tests Are Not Interchangeable
5. Common Medications Could Cause Physical Impairment in the Elderly
6. Commonly used medications associated with impaired physical function in older adults
7. NHP Declares Its Quarterly Cash Dividends on Common Stock and Series B Preferred Stock
8. Pennsylvania Pharmacy Carve-out Poses Risks for Commonwealths Neediest Citizens and Taxpayers, National Organization Testifies
9. Delusions Common in Pediatric ICU
10. Daily aspirin may reduce risk of common type of breast cancer
11. Kidney Care Community Applauds National Taxpayers Unions Endorsement of Medicare Reforms to Extend Patient Private Health Insurance Coverage; Calls Proposal Common Sense Coverage Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... ... athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures as ... City area —Johnson is one of the first doctors to perform the treatment. ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... ... is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is ...
(Date:6/24/2016)... TX (PRWEB) , ... June 24, 2016 , ... People ... part in Genome magazine’s Code Talker Award, an essay contest in which patients and ... an award to be presented at the 2016 National Society of Genetic Counselors (NSGC) ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
(Date:6/24/2016)... , June 24, 2016 ... Market by Type (Standard Pen Needles, Safety Pen Needles), ... (Insulin, GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) ... MarketsandMarkets, This report studies the market for the forecast ... to reach USD 2.81 Billion by 2021 from USD ...
(Date:6/24/2016)... 24, 2016  Arkis BioSciences, a leading innovator ... more durable cerebrospinal fluid treatments, today announced it ... funding is led by Innova Memphis, followed by ... private investors.  Arkis, new financing will accelerate the ... market release of its in-licensed Endexo® technology. ...
Breaking Medicine Technology: